Biomerica Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Biomerica, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2019FY 2018
Period EndingDec 2025May 2024May 2023May 2022May 2021May 2019May 2018
Revenue & Gross Profit
Revenue5.315.425.3418.877.205.205.56
Cost of Revenue4.814.804.8915.896.833.913.81
Gross Profit0.500.610.452.980.371.291.75
Operating Expenses
Research & Development1.021.491.581.812.191.681.40
Selling, General & Administrative4.615.496.095.7012.502.031.84
Operating Expenses5.646.987.677.517.873.703.24
Operating Income-5.14-6.37-7.22-4.53-7.50-2.41-1.48
Other Income/Expense
Interest Income0.170.430.130.030.070.040.05
Interest Expense0.000.000.000.000.000.000.00
Other Income/Expense0.170.000.00-0.03-0.070.000.00
Income
Income Before Tax-4.97-5.94-7.09-4.51-7.43-2.37-1.43
Income Tax Expense0.000.040.050.020.010.020.03
Net Income-4.97-5.98-7.14-4.53-7.45-2.39-1.47
Net Income - Continuous Operations-4.97-5.98-7.14-4.530.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-4.74-5.99-6.87-4.20-7.06-2.21-1.25
EBIT-5.14-6.37-7.22-4.53-7.43-2.37-1.43
Depreciation & Amortization0.400.370.350.340.110.000.00
Earnings Per Share
Basic EPS-2.00-3.00-4.00-3.00-1.00--
Diluted EPS-2.00-3.00-4.00-3.00-1.00--
Basic Shares Outstanding2.302.101.771.5811.939.218.57
Diluted Shares Outstanding2.302.101.771.5811.939.218.57